FIELD: medicine.
SUBSTANCE: it is suggested to apply tris-(2-hydroxyethyl)ammonium salt of 1-benzylindolyl-3-thioacetic acid earlier known as a stabilizer of cell membrane as preparation to treat autoimmune diseases. The property of the above-mentioned salt to inhibit T-dependent activation of B-lymphocytes, under conditions of decreased medullary function and body leukopenia should enable to develop new pharmacological preparation for treating autoimmune diseases, such as, for example, systemic lupus, rheumatoid polyarthritis, transplant's detachment at transplanting either organs or bony marrow.
EFFECT: higher efficiency of application.
4 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNODEPRESSANT | 2002 |
|
RU2228178C1 |
| IMMUNOSUPRESSOR | 2003 |
|
RU2253448C1 |
| IMMUNOMODULATING AGENT | 2003 |
|
RU2240794C1 |
| IMMUNOMODULATOR | 2003 |
|
RU2253445C1 |
| ANTI-TUMOR AGENT | 2003 |
|
RU2240793C1 |
| IMMUNOMODULATOR | 2003 |
|
RU2253444C1 |
| IMMUNOMODULATOR | 2003 |
|
RU2253447C1 |
| THE USE OF TRIS-(2-HYDROXYETHYL)AMMONIUM SALT OF 1-BENZYLINDOLYL-3-THIOACETIC ACID AS AN INHIBITOR OF THE ACTIVITY OF HUMAN ENDOGENOUS RETROVIRUS HERV-E λ 4-1 ENV | 2022 |
|
RU2801797C1 |
| IMMUNOMODULATING AGENT | 1993 |
|
RU2108100C1 |
| IMMUNOMODULATING AGENT | 2003 |
|
RU2245142C1 |
